Get the latest tech news
Is this the end of animal testing? Researchers are increasingly turning to organ-on-a-chip technology for drug testing and other applications.
Researchers are increasingly turning to organ-on-a-chip technology for drug testing and other applications.
“It was a conscious decision to focus on in vitro models.” He’s not alone; a growing number of young scientists are speaking up about the distress they feel when research protocols cause pain, trauma, injury, and death to lab animals. Dan Tagle, director of the Office of Special Initiatives for the National Center for Advancing Translational Sciences (NCATS), estimates that drug failures cost around $2.6 billion globally each year. Lorna Ewart, who spent 20 years at the pharma giant AstraZeneca before joining Emulate, thinks we’re entering a kind of transition time in research, in which scientists use in vitro technologies like organs on chips alongside traditional cell culture methods and animals.
Or read this on r/tech
